News
Jim Cramer, a stalwart of stock market commentary, recently shifted gears on Bristol-Myers Squibb, pegging his hopes on their ...
StockStory.org on MSN19h
Bristol-Myers Squibb (BMY): Buy, Sell, or Hold Post Q1 Earnings?Bristol-Myers Squibb’s shares (currently trading at $46.80) have posted a disappointing 18% loss, well below the S&P 500’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback